-+ 0.00%
-+ 0.00%
-+ 0.00%

Windtree Therapeutics Terminates Seismic-C-Clinical Study At 20 Enrollments; Termination Due To Limited Resources, Not Safety Concerns

Benzinga·08/08/2025 20:58:45
Listen to the news

-SEC Filing